Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeObject Symbol | Species | Term | Qualifier | Evidence | With | Notes | Source | Original Reference(s) | PVG.1AV1/Kini | Rat | decreased susceptibility to induced arthritis | penetrance | IAGP | pristane or squalene or type II collagen and Freund's incomplete adjuvant or Freund's complete adjuvant | compared to DA/ZtmKini | RGD | | PVG.1AV1/Kini | Rat | increased IgG1 level | | IAGP | type II collagen and Freund's incomplete adjuvant | compared to DA/ZtmKini | RGD | | DA.PVG.1AV1-(D4Rat63-D4Rat203) | Rat | increased IgG2b level | | IAGP | type II collagen and Freund's incomplete adjuvant | compared to DA/ZtmKini | RGD | | PVG.1AV1/Kini | Rat | increased IgG2b level | | IAGP | type II collagen and Freund's incomplete adjuvant | compared to DA/ZtmKini | RGD | | PVG.1AV1/Kini | Rat | increased IgG2c level | | IAGP | type II collagen and Freund's incomplete adjuvant | compared to DA/ZtmKini | RGD | | DA.PVG.1AV1-(D4Mgh17-D4Rat56) | Rat | increased susceptibility to induced arthritis | | IAGP | type II collagen and Freund's incomplete adjuvant | compared to PVG.1AV1/Kini | RGD | | DA.PVG.1AV1-(D4Rat155-Spr) | Rat | increased susceptibility to induced arthritis | | IAGP | pristane or type II collagen and Freund's incomplete adjuvant | compared to PVG.1AV1/Kini | RGD | | DA.PVG.1AV1-(D4Rat63-D4Rat203) | Rat | increased susceptibility to induced arthritis | | IAGP | type II collagen and Freund's incomplete adjuvant or pristane or squalene | compared to PVG.1AV1/Kini | RGD | | DA/Ztm | Rat | increased susceptibility to induced arthritis | penetrance | IAGP | pristane or squalene or type II collagen and Freund's incomplete adjuvant or Freund's complete adjuvant | compared to control strain PVG.1AV1 | RGD | | DA/ZtmKini | Rat | increased susceptibility to induced arthritis | | IAGP | pristane or squalene or type II collagen and Freund's incomplete adjuvant or Freund's complete adjuvant | compared to control strain PVG.1AV1/Kini | RGD | | DA.PVG.1AV1-(D4Mgh17-D4Rat56) | Rat | joint inflammation | sexual_dimorphism | IAGP | type II collagen and Freund's incomplete adjuvant | in males and compared to DA/ZtmKini | RGD | | DA.PVG.1AV1-(D4Rat155-D4Rat84) | Rat | joint inflammation | penetrance | IAGP | squalene or pristane or Freund's complete adjuvant or type II collagen and Freund's incomplete adjuvant | compared to DA/ZtmKini | RGD | | DA.PVG.1AV1-(D4Rat63-D4Rat203) | Rat | joint inflammation | susceptibility | IAGP | pristane | compared to PVG.1AV1/Kini | RGD | | DA.PVG.1AV1-(D4Rat63-D4Rat203) | Rat | joint inflammation | severity | IAGP | squalene or type II collagen and Freund's incomplete adjuvant | compared to DA/ZtmKini | RGD | | DA/ZtmKini | Rat | joint inflammation | susceptibility | IAGP | pristane or squalene or type II collagen and Freund's incomplete adjuvant or Freund's complete adjuvant | compared to control strain PVG.1AV1/Kini | RGD | | Oia8 | Rat | joint inflammation | | IAGP | | | RGD | | PVG.1AV1/Kini | Rat | joint inflammation | penetrance | IAGP | type II collagen and Freund's incomplete adjuvant or pristane | | RGD | | Pia22 | Rat | joint inflammation | | IAGP | | | RGD | | Pia7 | Rat | joint inflammation | | IAGP | | | RGD | | Pia9 | Rat | joint inflammation | | IAGP | | | RGD | | DA.PVG.1AV1-(D4Mgh17-D4Rat56) | Rat | weight loss | sexual_dimorphism | IAGP | type II collagen and Freund's incomplete adjuvant | in males and compared to DA/ZtmKini | RGD | | DA.PVG.1AV1-(D4Rat155-D4Rat84) | Rat | weight loss | | IAGP | Freund's complete adjuvant or squalene | compared to PVG.1AV1/Kini | RGD | | DA.PVG.1AV1-(D4Rat155-Spr) | Rat | weight loss | | IAGP | type II collagen and Freund's incomplete adjuvant or pristane | compared to PVG.1AV1/Kini | RGD | | DA.PVG.1AV1-(D4Rat63-D4Rat203) | Rat | weight loss | severity | IAGP | Freund's incomplete adjuvant and type II collagen | compared to DA/ZtmKini | RGD | | DA/ZtmKini | Rat | weight loss | susceptibility | IAGP | pristane or squalene or type II collagen and Freund's incomplete adjuvant or Freund's complete adjuvant | compared to control strain PVG.1AV1/Kini | RGD | | |